ZA83816B - Anti-viral compositions - Google Patents

Anti-viral compositions

Info

Publication number: ZA83816B
Authority: ZA; South Africa
Prior art keywords: salts; hsv; viral compositions; acid; halogenovinyl
Prior art date: 1982-02-12

Application number

ZA83816A

Other languages

English (en)

Inventor

Kendall O Smith

Original Assignee

Ens Bio Logicals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1982-02-12

Filing date

1983-02-07

Publication date

1983-12-28

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22167810&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA83816(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1983-02-07 Application filed by Ens Bio Logicals Inc filed Critical Ens Bio Logicals Inc

1983-12-28 Publication of ZA83816B publication Critical patent/ZA83816B/xx

Links

230000000840 anti-viral effect Effects 0.000 title 1
239000000203 mixture Substances 0.000 title 1
XUYJLQHKOGNDPB-UHFFFAOYSA-N phosphonoacetic acid Chemical compound OC(=O)CP(O)(O)=O XUYJLQHKOGNDPB-UHFFFAOYSA-N 0.000 abstract 2
ZJAOAACCNHFJAH-UHFFFAOYSA-N phosphonoformic acid Chemical compound OC(=O)P(O)(O)=O ZJAOAACCNHFJAH-UHFFFAOYSA-N 0.000 abstract 2
150000003839 salts Chemical class 0.000 abstract 2
208000029433 Herpesviridae infectious disease Diseases 0.000 abstract 1
241000700588 Human alphaherpesvirus 1 Species 0.000 abstract 1
241000701074 Human alphaherpesvirus 2 Species 0.000 abstract 1
MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
229960005102 foscarnet Drugs 0.000 abstract 1
IRSCQMHQWWYFCW-UHFFFAOYSA-N ganciclovir Chemical compound O=C1NC(N)=NC2=C1N=CN2COC(CO)CO IRSCQMHQWWYFCW-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Virology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Molecular Biology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Epidemiology (AREA)
Biotechnology (AREA)
Engineering & Computer Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

ZA83816A 1982-02-12 1983-02-07 Anti-viral compositions ZA83816B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/US1982/000182 WO1983002723A1 (fr)	1982-02-12	1982-02-12	Compositions anti-virales

Publications (1)

Publication Number	Publication Date
ZA83816B true ZA83816B (en)	1983-12-28

Family

ID=22167810

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA83816A ZA83816B (en)	1982-02-12	1983-02-07	Anti-viral compositions

Country Status (9)

Country	Link
EP (1)	EP0101441B1 (fr)
JP (1)	JPS59500317A (fr)
AT (1)	ATE24836T1 (fr)
DE (1)	DE3275061D1 (fr)
HK (1)	HK78089A (fr)
IT (1)	IT1212699B (fr)
MC (1)	MC1585A1 (fr)
WO (1)	WO1983002723A1 (fr)
ZA (1)	ZA83816B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4462986A (en) *	1982-11-04	1984-07-31	Ens Bio Logicals, Inc.	Synergistic anti-herpes compositions
IT1170232B (it) *	1983-10-31	1987-06-03	Anna Gioia Stendardi	Composizioni terapeutiche ad attivita' antivirale
WO1992009285A1 (fr) *	1990-11-27	1992-06-11	The Procter & Gamble Company	Combinaisons de composes vanilloides et de composes phosphonates antiviraux pour le traitement d'infections par herpes
CA2150671C (fr) *	1992-12-03	2000-12-26	Sai P. Sunkara	Compositions contenant des composes analogues a l'acyclovir et des analogues du 2'-vinyl-nucleoside substitue pour le traitement d'infections virales
WO1996001638A1 (fr) *	1994-07-11	1996-01-25	Hoechst Marion Roussel, Inc.	Procede de traitement du stade neoplasique d'une affection par therapie associant des derives de 2'-fluorometylidene et une radiotherapie ou chimiotherapie
CZ284920B6 (cs) *	1996-02-14	1999-04-14	Vladimír Prof. Mudr. Drsc. Vonka	Preparáty pro léčbu rekurentního herpesu založené na potenciaci účinků syntetických virostatik kofeinem

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3767795A (en) *	1971-02-25	1973-10-23	Abbott Lab	Method for combating certain virus infection
GB1523865A (en) *	1974-09-02	1978-09-06	Wellcome Found	Purine compunds and salts thereof
US4199574A (en) *	1974-09-02	1980-04-22	Burroughs Wellcome Co.	Methods and compositions for treating viral infections and guanine acyclic nucleosides
SE7607496L (sv) *	1976-07-01	1978-01-02	Astra Laekemedel Ab	Sett for bekempning av virusinfektioner

1982
- 1982-02-12 AT AT82901187T patent/ATE24836T1/de not_active IP Right Cessation
- 1982-02-12 WO PCT/US1982/000182 patent/WO1983002723A1/fr not_active Ceased
- 1982-02-12 DE DE8282901187T patent/DE3275061D1/de not_active Expired
- 1982-02-12 MC MC82US8200182D patent/MC1585A1/fr unknown
- 1982-02-12 JP JP57501235A patent/JPS59500317A/ja active Granted
- 1982-02-12 EP EP82901187A patent/EP0101441B1/fr not_active Expired
1983
- 1983-02-07 ZA ZA83816A patent/ZA83816B/xx unknown
- 1983-02-14 IT IT8319583A patent/IT1212699B/it active
1989
- 1989-09-28 HK HK780/89A patent/HK78089A/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP0101441A1 (fr)	1984-02-29
JPH0138770B2 (fr)	1989-08-16
ATE24836T1 (de)	1987-01-15
EP0101441A4 (fr)	1985-04-11
DE3275061D1 (en)	1987-02-19
WO1983002723A1 (fr)	1983-08-18
EP0101441B1 (fr)	1987-01-14
IT8319583A0 (it)	1983-02-14
IT1212699B (it)	1989-11-30
MC1585A1 (fr)	1985-02-22
HK78089A (en)	1989-10-06
JPS59500317A (ja)	1984-03-01

Similar Documents

Publication	Publication Date	Title
ATE91233T1 (de)	1993-07-15	Antivirale pharmazeutische zusammensetzungen und ihrer verwendung.
GB2167283B (en)	1989-05-24	Improvements in or relating to a method of making an improved food composition.
EP0498471A3 (en)	1993-03-03	Liposomes comprising a guanidino aminoglycoside
DE3752112D1 (de)	1997-10-02	Verwendung von Inositoltriphosphat zur Behandlung von Entzündungen
BR9811028A (pt)	2000-08-01	Composto, composição farmacêutica, e, processos de tratamento de uma doença de agregação de plaquetas e para a preparação de um composto
HK77989A (en)	1989-10-06	Compositions comprising interferon and their therapeutic use
DE3275061D1 (en)	1987-02-19	Anti-viral compositions
ES2108014T3 (es)	1997-12-16	Composicion antiviral de 3'-azido-2',3'-dideoxi-5-metilcitidina.
ZA841241B (en)	1984-12-24	Dimethylaminomethylenated anti-herpes compounds
EP0500953A4 (en)	1993-04-21	Antineoplastic effect potentiator and antineoplastic agent
IL75368A (en)	1989-07-31	Process for combating varoatosis in bees with coumaphos
FR2534809B1 (fr)	1985-06-28	Association medicamenteuse, renfermant a titre de principes actifs, un analgesique central et la vitamine b 12 ou un derive de celle-ci
IE55973B1 (en)	1991-03-13	The use of undecylenic acid for the manufacture of a composition for the treatment of herpes labialis
ZA935718B (en)	1995-02-06	Liponucleotides of seco-nucleosides and pharmaceutical compositions with antiviral action containing them
CA2207503A1 (fr)	1996-06-20	Emploi d'agents antiviraux a base d'aminopurine pour le traitement et la prophylaxie d'infections latentes par les herpesvirus
FI833504A7 (fi)	1984-03-31	9-(1,3-dihydroksi-2- propoksimetyyli)guaniinin 1- monofosfaattiesterit, 1,3-bisfosfaattiestbisfosfaattiesterit ja sykliset fosfaattiesterit antiviraalisina aineiaineina.
ZA804117B (en)	1981-08-26	Synergistic antihypertensive compositions
Smith	1990	Anti-viral compositions.
GB2002339A (en)	1979-02-21	Increasing root yield and sugar content of sugar beet
DE3579140D1 (de)	1990-09-13	Arzneimittel mit einem 6-substituierten adenosin als aktives bestandteil.
SU1210416A1 (ru)	1999-12-27	Аммониевая соль 2-метилтио-6-нитро-7-оксо-4,7-дигидро-1,2,4-триазоло[5,1-c][1,2,4]-триазин а, обладающая противовирусной активностью
JPS5690015A (en)	1981-07-21	Preventive and remedy containing human ceruloplasmin as main component
IT8319981A0 (it)	1983-03-09	Composti ad attivita' antivirale, procedimento per la loro preparazione e composizioni farmaceutiche cheli contengono.
IE821856L (en)	1983-02-01	5-(2-halogenovinyl) -2' -deoxyuridine antiviral agents
IT8920927A0 (it)	1989-06-20	Procedimenti per la preparazione di composti prostanoici ad attivita' antiaggregante piastrinica, antitrombotica, composizioni farmaceutiche che li contengono.